Target intelligence / Profile preview

Glucuronidase, beta pseudogene 9 (GUSBP9)

Target
GUSBP9
Molecular classification
Pseudogene, Processed pseudogene (if annotation confirms loss of coding function)
01

Overview

GUSB pseudogene 9 (GUSBP9) is a non-coding genomic segment derived from the GUSB gene and annotated as a pseudogene, typically due to disruptive mutations such as frameshifts or premature stop codons that render it non-functional[3][4][5]. Unlike the active GUSB gene, which encodes a lysosomal hydrolase involved in glycosaminoglycan metabolism and is relevant to inherited metabolic disorders, GUSBP9 does not produce a functional protein nor is it associated with biological or pharmacological functions. Pseudogenes, in general, may sometimes affect gene regulation at the RNA level, but no experimental data currently support such a role for GUSBP9. It is not considered a drug target, biomarker, or therapeutic entity. There is nothing to indicate active transcript, peptide, receptor, or enzyme function; the gene is likely included in annotation databases solely for completeness as a non-functional paralog in the human genome[3][4].

Other names
GUSB pseudogene 9glucuronidase, beta pseudogene 9GUSBP9
02

Mechanism of action

Not applicable (no drug interaction or target function)

03

Biological functions

No protein-coding functionNo confirmed endogenous regulatory or enzymatic activityPseudogenes sometimes regulate parental gene expression via RNA-based mechanisms, but there is no published evidence for GUSBP9 specifically
04

Disease associations

None established for GUSBP9No reported association with specific diseasesThe parental GUSB gene is implicated in mucopolysaccharidosis type VII, but GUSBP9 does not share function or disease relevance

Beyond the preview

Go deeper on Glucuronidase, beta pseudogene 9 (GUSBP9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glucuronidase, beta pseudogene 9 (GUSBP9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call